Literature DB >> 15576275

Plasma endothelin-1 and clinical manifestations of neonatal sepsis.

José Figueras-Aloy1, Lilian Gómez-Lopez, J Manuel Rodríguéz-Miguélez, Yolanda Jordán-García, M Dolores Salvia-Roiges, Wladimiro Jiménez, Xavier Carbonell-Estrany.   

Abstract

AIM: To determine whether plasma endothelin-1 (ET-1) relates to clinical manifestations of sepsis in the newborn, especially with systemic hypotension, acidosis, severe hypoxemia (which may represent pulmonary hypertension) and oliguria.
METHODS: Prospective study of 35 consecutive newborns with clinical sepsis: 22 with hemoculture-positive (HC+) sepsis and 13 hemoculture-negative (HC-). Plasma ET-1 concentrations were measured within 2 days of the diagnosis of sepsis. SNAP-II severity score was performed at the time of highest clinical severity.
RESULTS: Newborns with HC+ sepsis had higher plasma ET-1 concentrations and SNAP-II scores (especially PO 2 /FiO 2 ratio) than HC- septic children. Plasma ET-1 concentrations increased linearly with each item of the SNAP-II score, but only reached significant differences in lowest mean blood pressure (P=0.030), lowest pH (P=0.048), multiple seizures (P=0.010) and lowest urine output (P=0.013). Leukocyte count, immature/total neutrophil ratio and C-reactive protein value were not different. Each item of the SNAP-II score was independently related only to ET-1 level. Oliguria, acidosis and systemic hypotension were more correlated (R 2 >0.5).
CONCLUSIONS: Plasma ET-1 levels in neonatal sepsis are related to the severity of clinical manifestations, especially oliguria, acidosis and systemic hypotension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15576275     DOI: 10.1515/JPM.2004.126

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  14 in total

Review 1.  Endothelin-1 and its role in the pathogenesis of infectious diseases.

Authors:  Brandi D Freeman; Fabiana S Machado; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Life Sci       Date:  2014-04-26       Impact factor: 5.037

Review 2.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

3.  Endothelin-1-Rho kinase interactions impair lung structure and cause pulmonary hypertension after bleomycin exposure in neonatal rat pups.

Authors:  Jason Gien; Nancy Tseng; Gregory Seedorf; Katherine Kuhn; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-19       Impact factor: 5.464

4.  Endothelin receptor antagonist attenuates inflammatory response and prolongs the survival time in a neonatal sepsis model.

Authors:  Tatenobu Goto; Mohamed Hamed Hussein; Shin Kato; Ghada Abdel-Hamid Daoud; Takenori Kato; Hiroki Kakita; Haruo Mizuno; Masaki Imai; Tetsuya Ito; Ineko Kato; Satoshi Suzuki; Noriko Okada; Hajime Togari; Hidechika Okada
Journal:  Intensive Care Med       Date:  2010-09-16       Impact factor: 17.440

5.  Combination therapy for life-threatening pulmonary hypertension in a premature infant: first report on bosentan use.

Authors:  Maurizio Radicioni; Alessia Bruni; Piergiorgio Camerini
Journal:  Eur J Pediatr       Date:  2011-03-08       Impact factor: 3.183

Review 6.  Hemodynamic dysfunction in neonatal sepsis.

Authors:  Ashraf Kharrat; Amish Jain
Journal:  Pediatr Res       Date:  2021-11-24       Impact factor: 3.756

7.  Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep.

Authors:  Jason Gien; Nancy Tseng; Gregory Seedorf; Gates Roe; Steven H Abman
Journal:  Pediatr Res       Date:  2012-11-30       Impact factor: 3.756

Review 8.  A Systematic Review: The Utility of the Revised Version of the Score for Neonatal Acute Physiology Among Critically Ill Neonates.

Authors:  Shannon Morse; Maureen Groer; Melissa M Shelton; Denise Maguire; Terri Ashmeade
Journal:  J Perinat Neonatal Nurs       Date:  2015 Oct-Dec       Impact factor: 1.638

Review 9.  Current trends in inflammatory and immunomodulatory mediators in sepsis.

Authors:  Monowar Aziz; Asha Jacob; Weng-Lang Yang; Akihisa Matsuda; Ping Wang
Journal:  J Leukoc Biol       Date:  2012-11-07       Impact factor: 4.962

10.  Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin.

Authors:  Lars A Schneider; Susan M Schlenner; Thorsten B Feyerabend; Markus Wunderlin; Hans-Reimer Rodewald
Journal:  J Exp Med       Date:  2007-10-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.